The Trump Administration scraps plan to ban rebates on drugs in Medicare Part D, and more news to know.
Despite what many expect, high-performing pharmacies often still have to deal with DIR fees. Here’s why.
Amid a shortage of EpiPens, Novartis is extending the availability of its generic pre-filled epinephrine shots to pharmacies across the U.S., and more news to know.
Earlier this year, CMS released updates to Medicare Advantage and Part D programs for the upcoming plan year. As we look ahead to Open Enrollment, here’s a breakdown of some of the major changes.
A bipartisan bill could help provide shingles and Tdap vaccinations to Medicare beneficiaries at no extra cost, and more news to know.
Despite the known benefits of naloxone, approaching the conversation about its necessity with patients is not always easy for pharmacists. Here are a few things to keep in mind when making the case for naloxone.
Drug makers are suing the government to block a new rule requiring drug prices in TV ads, and more news to know this week.
Medication non-adherence adversely affects patients and pharmacies alike, but with effective communication and proactive interventions, pharmacists can help patients stay on track.
As the push to minimize tobacco use continues, pharmacists are seeing an increasing number of opportunities to help smokers looking to kick the habit.
In this Q&A, T.W. Taylor, Pharm.D., owner of Williamsburg Drug Co., shares his successes with CBD at his pharmacy, how he addresses patient concerns, and advice for pharmacies looking to break into the CBD market.